Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 20, 2019 - Issue 16
Submit an article Journal homepage
208
Views
2
CrossRef citations to date
0
Altmetric
Original Research

A post hoc analysis on hospitalization risk in Asian patients with schizophrenia switching to once-monthly paliperidone palmitate from oral antipsychotics

Nan LiResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, ChinaView further author information
,
Jian Min ZhuoJanssen China Research & Development, Johnson & Johnson (China) Investment Ltd., Shanghai, ChinaView further author information
,
Ibrahim TurkozJanssen Research & Development, LLC, Titusville, NJ, USAView further author information
,
Maju MathewsJanssen Research & Development, LLC, Titusville, NJ, USAView further author information
,
Yu FengJanssen Pharmaceutical Companies of Johnson and Johnson, Singapore, SingaporeView further author information
&
Wilson TanJanssen Pharmaceutical Companies of Johnson and Johnson, Singapore, SingaporeCorrespondence[email protected]
View further author information
Pages 2033-2039 | Received 30 May 2019, Accepted 26 Jul 2019, Published online: 08 Aug 2019

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ning Ma, Lei Zhang, Wufang Zhang, Yingying He, Chong Ye & Xin Li. (2023) Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review. Neuropsychiatric Disease and Treatment 19, pages 1987-2006.
Read now

Articles from other publishers (1)

Qian Li, Xin Li, Chong Ye, Miaomiao Jia & Tianmei Si. (2023) Effectiveness and Safety of Switching from Oral Antipsychotics to Once-Monthly Paliperidone Palmitate (PP1M) in the Management of Schizophrenia: A Systematic Review and Meta-Analysis. CNS Drugs 37:8, pages 695-713.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.